The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 03, 2023
Filed:
Sep. 15, 2017
Applicant:
Hoffmann-la Roche Inc., Little Falls, NJ (US);
Assignee:
Hoffmann-La Roche Inc., Little Falls, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 31/506 (2006.01); A61K 31/40 (2006.01); A61K 31/5355 (2006.01); A61K 31/7064 (2006.01); A61P 31/20 (2006.01); A61P 1/16 (2006.01); A61K 31/216 (2006.01); A61K 31/381 (2006.01); A61K 31/426 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/216 (2013.01); A61K 31/381 (2013.01); A61K 31/40 (2013.01); A61K 31/426 (2013.01); A61K 31/506 (2013.01); A61K 31/5355 (2013.01); A61K 31/7064 (2013.01); A61P 1/16 (2018.01); A61P 31/20 (2018.01); A61K 2300/00 (2013.01);
Abstract
The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a TLR7 agonist and an HBV capsid assembly inhibitor for use in the treatment of chronic hepatitis B patient.